Colorectal Cancer: NILK-2301 Antibody Study

We are testing a new antibody treatment for patients with colorectal cancer to see how safe it is and how well it works. This study aims to gather important information for future treatments.

>2 yearsSafety phase (I)GastroenterologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Vall D'hebron Institut De Recerca
Oncology
Barcelona, Spain
Sponsor: NovImmune S.A.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.